Amy W Amara1, Harrison C Walker1,2, Allen Joop1, Gary Cutter3, Jennifer L DeWolfe4, Susan M Harding5, David G Standaert1. 1. 1Division of Movement Disorders, Department of Neurology, University of Alabama at Birmingham, Birmingham, AL. 2. Department of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, AL. 3. Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, AL. 4. Division of Epilepsy, Department of Neurology, University of Alabama at Birmingham, Birmingham, AL. 5. Division of Pulmonary, Allergy, and Critical Medicine Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.
Abstract
BACKGROUND: Sleep dysfunction is a common and disabling non-motor symptom in Parkinson's disease. Deep brain stimulation (DBS) of the subthalamic nucleus (STN) improves motor symptoms and subjective sleep in PD, but alternative stimulation parameters to optimize sleep have not been explored. We hypothesized that low frequency STN DBS would improve objective sleep more than conventional settings. METHODS: Twenty PD subjects with STN DBS (18 unilateral, 2 bilateral) underwent 3 non-consecutive nights of polysomnography: DBS off; DBS high frequency (≥130 Hz); and DBS low frequency (60 Hz). Motor symptom tolerability was assessed 30 minutes after resumption of baseline settings the morning following polysomnography. The primary outcome was change in sleep efficiency between high and low frequency nights measured with repeated measures ANOVA. RESULTS: There was no difference in sleep efficiency between nights at high frequency (82.1% (72.6-90.1)) (median (IQR)), low frequency (81.2% (56.2-88.8)), or DBS off (82.8% (75.7-87.4)), p=0.241. Additionally, there was no difference in sleep stage percent, arousals, limb movements, subjective sleep quality, or objective vigilance measures. These outcomes did not change after adjusting for age, sex, disease duration, or side of surgery. No residual adverse motor effects were noted. CONCLUSIONS: Although well tolerated, low frequency STN DBS did not improve objective sleep in PD. Remarkably, objective measures of sleep were not worse with DBS off. These observations point to the potential for adaptive stimulation approaches, through which DBS settings could be optimized during sleep to meet individual needs. Additionally, these changes could preserve battery life without compromising patient outcomes.
BACKGROUND:Sleep dysfunction is a common and disabling non-motor symptom in Parkinson's disease. Deep brain stimulation (DBS) of the subthalamic nucleus (STN) improves motor symptoms and subjective sleep in PD, but alternative stimulation parameters to optimize sleep have not been explored. We hypothesized that low frequency STN DBS would improve objective sleep more than conventional settings. METHODS: Twenty PD subjects with STN DBS (18 unilateral, 2 bilateral) underwent 3 non-consecutive nights of polysomnography: DBS off; DBS high frequency (≥130 Hz); and DBS low frequency (60 Hz). Motor symptom tolerability was assessed 30 minutes after resumption of baseline settings the morning following polysomnography. The primary outcome was change in sleep efficiency between high and low frequency nights measured with repeated measures ANOVA. RESULTS: There was no difference in sleep efficiency between nights at high frequency (82.1% (72.6-90.1)) (median (IQR)), low frequency (81.2% (56.2-88.8)), or DBS off (82.8% (75.7-87.4)), p=0.241. Additionally, there was no difference in sleep stage percent, arousals, limb movements, subjective sleep quality, or objective vigilance measures. These outcomes did not change after adjusting for age, sex, disease duration, or side of surgery. No residual adverse motor effects were noted. CONCLUSIONS: Although well tolerated, low frequency STN DBS did not improve objective sleep in PD. Remarkably, objective measures of sleep were not worse with DBS off. These observations point to the potential for adaptive stimulation approaches, through which DBS settings could be optimized during sleep to meet individual needs. Additionally, these changes could preserve battery life without compromising patient outcomes.
Entities:
Keywords:
Deep Brain Stimulation; Parkinson’s Disease; Sleep; Subthalamic Nucleus; Vigilance
Authors: Juan Carlos Gómez-Esteban; Beatriz Tijero; Johanne Somme; Roberto Ciordia; Koldo Berganzo; Idoia Rouco; Jose Luis Bustos; Maria Antonia Valle; Elena Lezcano; Juan J Zarranz Journal: J Neurol Date: 2010-10-19 Impact factor: 4.849
Authors: C Monaca; C Ozsancak; J M Jacquesson; I Poirot; S Blond; A Destee; J D Guieu; P Derambure Journal: J Neurol Date: 2004-02 Impact factor: 4.849
Authors: Kristin J Ford; Allen Joop; Raima A Memon; Kimberly H Wood; Karlene Ball; Gary R Cutter; David C Schwebel; Amy W Amara Journal: Mov Disord Date: 2017-10-04 Impact factor: 10.338
Authors: Kimberly H Wood; Adeel A Memon; Raima A Memon; Allen Joop; Jennifer Pilkington; Corina Catiul; Adam Gerstenecker; Kristen Triebel; Gary Cutter; Marcas M Bamman; Svjetlana Miocinovic; Amy W Amara Journal: J Parkinsons Dis Date: 2021 Impact factor: 5.568
Authors: Amy W Amara; Kimberly H Wood; Allen Joop; Raima A Memon; Jennifer Pilkington; S Craig Tuggle; John Reams; Matthew J Barrett; David A Edwards; Arthur L Weltman; Christopher P Hurt; Gary Cutter; Marcas M Bamman Journal: Mov Disord Date: 2020-02-24 Impact factor: 10.338